LU69872A1 - - Google Patents
Info
- Publication number
- LU69872A1 LU69872A1 LU69872A LU69872A LU69872A1 LU 69872 A1 LU69872 A1 LU 69872A1 LU 69872 A LU69872 A LU 69872A LU 69872 A LU69872 A LU 69872A LU 69872 A1 LU69872 A1 LU 69872A1
- Authority
- LU
- Luxembourg
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
- C07D231/22—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
- C07D231/24—One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms having sulfone or sulfonic acid radicals in the molecule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/18—One oxygen or sulfur atom
- C07D231/20—One oxygen atom attached in position 3 or 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/44—Oxygen and nitrogen or sulfur and nitrogen atoms
- C07D231/52—Oxygen atom in position 3 and nitrogen atom in position 5, or vice versa
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2319280A DE2319280A1 (de) | 1973-04-17 | 1973-04-17 | 1-substituierte pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| DE2363139A DE2363139A1 (de) | 1973-12-19 | 1973-12-19 | 1-substituierte pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU69872A1 true LU69872A1 (pl) | 1974-11-28 |
Family
ID=25764996
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU69872A LU69872A1 (pl) | 1973-04-17 | 1974-04-16 |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US3957814A (pl) |
| JP (1) | JPS5314071B2 (pl) |
| AR (5) | AR207444A1 (pl) |
| AT (1) | AT337176B (pl) |
| BG (5) | BG21405A3 (pl) |
| CA (1) | CA1034953A (pl) |
| CH (5) | CH603592A5 (pl) |
| DD (1) | DD113757A5 (pl) |
| DK (1) | DK136066C (pl) |
| EG (1) | EG11157A (pl) |
| ES (3) | ES425373A1 (pl) |
| FI (1) | FI57587C (pl) |
| FR (1) | FR2226172B1 (pl) |
| GB (1) | GB1429141A (pl) |
| HK (1) | HK70276A (pl) |
| HU (1) | HU168590B (pl) |
| IE (1) | IE39212B1 (pl) |
| IL (1) | IL44626A (pl) |
| LU (1) | LU69872A1 (pl) |
| NL (1) | NL177917C (pl) |
| NO (1) | NO138530C (pl) |
| PH (1) | PH14829A (pl) |
| PL (1) | PL96883B1 (pl) |
| RO (2) | RO69740A (pl) |
| SE (1) | SE408301B (pl) |
| SU (2) | SU541430A3 (pl) |
| YU (1) | YU104874A (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4056533A (en) * | 1973-04-17 | 1977-11-01 | Bayer Aktiengesellschaft | Pyrazol-5-ones |
| DE2526467A1 (de) * | 1975-06-13 | 1976-12-30 | Bayer Ag | 4-substituierte pyrazolderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| DE3306366A1 (de) * | 1983-02-24 | 1984-08-30 | Bayer Ag, 5090 Leverkusen | Muzolimin enthaltende arzneimittel, deren verwendung und verfahren zu deren herstellung |
| US4663327A (en) * | 1984-05-23 | 1987-05-05 | Bayer Aktiengesellschaft | 1-heteroaryl-4-aryl-pyrazolin-5-ones |
| JPH0730031B2 (ja) * | 1986-04-02 | 1995-04-05 | 日産化学工業株式会社 | ２―ピラゾリン―５―オン類の製造法 |
| DE3738963A1 (de) * | 1987-11-17 | 1989-05-24 | Bayer Ag | 3-aminopyrazolin-5-one |
| US5711929A (en) * | 1989-05-06 | 1998-01-27 | 698638 Alberta Ltd. | Purification of elemental sulphur |
| GB8912861D0 (en) * | 1989-06-05 | 1989-07-26 | Sherritt Gordon Ltd | Purification of elemental sulphur |
| US5300514A (en) * | 1990-07-17 | 1994-04-05 | Eli Lilly And Company | Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations thereof |
| US5399565A (en) * | 1990-07-17 | 1995-03-21 | Eli Lilly And Company | Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations therof |
| DE69131268T2 (de) * | 1990-09-21 | 1999-12-30 | Rohm And Haas Co., Philadelphia | Dihydropyridazinone und Pyridazinone als Fungizide |
| CN1038249C (zh) * | 1991-08-28 | 1998-05-06 | 罗姆和哈斯公司 | 含有二氢哒嗪酮及其相关化合物的杀菌组合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2376380A (en) * | 1945-05-22 | Preparation of amino pyrazolones | ||
| GB636988A (en) * | 1947-12-24 | 1950-05-10 | Gevaert Photo Producten Naamlo | Improvements in and relating to the production of colour photographic images |
| US2511231A (en) * | 1949-03-26 | 1950-06-13 | Eastman Kodak Co | 1-cyanophenyl-3-acylamino-5-pyrazolone couplers for color photography |
| US2600788A (en) * | 1949-06-07 | 1952-06-17 | Eastman Kodak Co | Halogen-substituted pyrazolone couplers for color photography |
| US2672417A (en) * | 1949-12-31 | 1954-03-16 | Gevaert Photo Prod Nv | Production of color photographic images |
| NL279140A (pl) * | 1961-05-31 |
-
1974
- 1974-01-01 AR AR253331A patent/AR207444A1/es active
- 1974-03-29 FR FR7411495A patent/FR2226172B1/fr not_active Expired
- 1974-04-09 HU HUBA3058A patent/HU168590B/hu unknown
- 1974-04-11 FI FI1105/74A patent/FI57587C/fi active
- 1974-04-12 BG BG027980A patent/BG21405A3/xx unknown
- 1974-04-12 BG BG026395A patent/BG21217A3/xx unknown
- 1974-04-12 BG BG027979A patent/BG22821A3/xx unknown
- 1974-04-12 BG BG027977A patent/BG21857A3/xx unknown
- 1974-04-12 IL IL44626A patent/IL44626A/xx unknown
- 1974-04-12 BG BG027978A patent/BG21218A3/xx unknown
- 1974-04-15 YU YU01048/74A patent/YU104874A/xx unknown
- 1974-04-15 RO RO7485201A patent/RO69740A/ro unknown
- 1974-04-15 US US05/461,282 patent/US3957814A/en not_active Expired - Lifetime
- 1974-04-15 JP JP4111274A patent/JPS5314071B2/ja not_active Expired
- 1974-04-15 RO RO7400078420A patent/RO63749A/ro unknown
- 1974-04-15 PH PH15730A patent/PH14829A/en unknown
- 1974-04-15 DD DD177913A patent/DD113757A5/xx unknown
- 1974-04-16 NO NO741365A patent/NO138530C/no unknown
- 1974-04-16 ES ES425373A patent/ES425373A1/es not_active Expired
- 1974-04-16 PL PL1974170378A patent/PL96883B1/pl unknown
- 1974-04-16 NL NLAANVRAGE7405115,A patent/NL177917C/xx not_active IP Right Cessation
- 1974-04-16 CH CH524274A patent/CH603592A5/xx not_active IP Right Cessation
- 1974-04-16 DK DK208074A patent/DK136066C/da not_active IP Right Cessation
- 1974-04-16 LU LU69872A patent/LU69872A1/xx unknown
- 1974-04-16 CH CH156477A patent/CH605801A5/xx not_active IP Right Cessation
- 1974-04-16 EG EG119/74A patent/EG11157A/xx active
- 1974-04-16 SE SE7405078A patent/SE408301B/sv not_active IP Right Cessation
- 1974-04-16 CH CH156577A patent/CH605800A5/xx not_active IP Right Cessation
- 1974-04-16 CH CH156377A patent/CH596172A5/xx not_active IP Right Cessation
- 1974-04-16 AT AT313274A patent/AT337176B/de not_active IP Right Cessation
- 1974-04-16 CH CH156677A patent/CH605797A5/xx not_active IP Right Cessation
- 1974-04-16 GB GB1650774A patent/GB1429141A/en not_active Expired
- 1974-04-17 CA CA197,660A patent/CA1034953A/en not_active Expired
- 1974-04-17 IE IE798/74A patent/IE39212B1/xx unknown
-
1975
- 1975-01-01 AR AR258508A patent/AR205272A1/es active
- 1975-01-01 AR AR258506A patent/AR208192A1/es active
- 1975-01-01 AR AR258507A patent/AR205271A1/es active
- 1975-03-19 SU SU2114308A patent/SU541430A3/ru active
- 1975-03-19 SU SU2115103A patent/SU539525A3/ru active
- 1975-04-25 AR AR258505A patent/AR204951A1/es active
-
1976
- 1976-04-15 ES ES447064A patent/ES447064A1/es not_active Expired
- 1976-04-15 ES ES447063A patent/ES447063A1/es not_active Expired
- 1976-11-11 HK HK702/76*UA patent/HK70276A/xx unknown